Skip to main content
. 2018 Jun 14;25(1):1448–1460. doi: 10.1080/10717544.2018.1482974

Figure 4.

Figure 4.

(A) Release profiles of VP from the optimized system (“OS”) compared to the market product (Isoptin®); while (B) shows the FTIR spectrum of pure VP (B1), PCL (B2), drug free PCL beads (B3), and optimized VP-loaded PCL beads (B4).